BEIJING, Aug. 11 Sinovac Biotech Ltd. (Amex: SVA),a vaccine-focused biotech company in China, announced today that it will holdits 2007 Annual Meeting of Shareholders on Thursday, September 4, 2008 at 9:00a.m. Beijing Time. The meeting will be held concurrently at No. 39 Shangdi XiRoad, Haidian District, Beijing, PRC and at No. 6 Temple Street, St. John's,Antigua. All shareholders of record as of August 1, 2008 will be eligible tovote and are invited to attend.
Sinovac Biotech Ltd.'s 2007 Annual Report, notice of annual generalmeeting and proxy statement are available on the investors section of theCompany's website http://www.sinovac.com .
Sinovac Biotech Ltd. is a China-based biopharmaceutical company thatfocuses on the research, development, manufacture and commercialization ofvaccines that protect against human infectious diseases. Sinovac'scommercialized vaccines include Healive(R) (hepatitis A), Bilive(R) (combinedhepatitis A and B), Anflu(R) (influenza) and Panflu(TM) (H5N1). Sinovac iscurrently developing Universal Pandemic Influenza vaccine and Japaneseencephalitis vaccine. Additional information about Sinovac is available onits website, http://www.sinovac.com . To be added to our distribution list,please email: [email protected]
Safe Harbor Statement
This announcement contains forward-looking statements. These statementsare made under the "safe harbor" provisions of the U.S. Private SecuritiesLitigation Reform Act of 1995. These forward-looking statements can beidentified by words or phrases such as "will," "expects," "anticipates,""future," "intends," "plans," "believes," "estimates" and similar statements.Among other things, the business outlook and quotations from management inthis press release contain forward-looking statements. Statements that are nothistorical facts, including statements about Sinovac's beliefs andexpectations, are forward-looking statements. Forward-looking statementsinvolve inherent risks and uncertainties. A number of important factors couldcause actual results to differ materially from those contained in anyforward-looking statement. Sinovac does not undertake any obligation toupdate any forward-looking statement, except as required under applicable law.For more information, please contact: Helen G. Yang Sinovac Biotech Ltd. Tel: +86-10-8289-9871 Fax: +86-10-6296-6910 Email: [email protected]
Investors: Stephanie Carrington The Ruth Group Tel: +1-646-536-7017 Email: [email protected]
Media: Janine McCargo The Ruth Group Tel: +1-646-536-7033 Email: [email protected]
SOURCE Sinovac Biotech Ltd.